Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multidrug-resistant tuberculous meningitis.

Thomas F Byrd1, Larry E Davis

  • 1Department of Medicine, New Mexico Veterans Affairs Health Care System, 1501 San Pedro SE, Albuquerque, NM 87108, USA. tbyrd@salud.unm.edu

Current Neurology and Neuroscience Reports
|November 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inducible Ift88-deficient mice show features consistent with mild pulmonary hypertension.

Physiological reports·2026
Same author

Implementation of Passive Deterioration Index Alerts in an Intermediate Care Unit: A Failed Early Warning System Strategy.

Applied clinical informatics·2025
Same author

Beyond Unplanned ICU Transfers: Linking a Revised Definition of Deterioration to Patient Outcomes.

Critical care medicine·2024
Same author

A Retrospective Cohort Study Comparing Dual Therapy With Ceftaroline With Vancomycin or Daptomycin Monotherapy for High-Grade or Persistent MRSA Bacteremia.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians·2024
Same author

Short versus long duration of ceftaroline combination therapy and outcomes in persistent or high-grade MRSA bacteremia: A retrospective single-center study.

PloS one·2024
Same author

Validation of a Proprietary Deterioration Index Model and Performance in Hospitalized Adults.

JAMA network open·2023
Same journal

The Noradrenergic Brain in Parkinson's Disease.

Current neurology and neuroscience reports·2026
Same journal

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

Current neurology and neuroscience reports·2026
Same journal

Functional and Structural Brain Imaging Correlates of Treatment Response in Functional Movement Disorder.

Current neurology and neuroscience reports·2026
Same journal

Astrocytopathy in Wernicke Encephalopathy and Neuromyelitis Optica Spectrum Disorder. Pathogenic Differences With Occasional Clinical and Neuroimaging Overlap. A Review.

Current neurology and neuroscience reports·2026
Same journal

When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?

Current neurology and neuroscience reports·2026
Same journal

Assessment and Management of Post-traumatic Headache.

Current neurology and neuroscience reports·2026
See all related articles

Multidrug-resistant tuberculous meningitis is a growing global threat, challenging diagnosis and treatment. Advances in rapid diagnostics and new drug development are crucial for effective patient management.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Microbiology

Background:

  • Multidrug-resistant tuberculous meningitis (MDR-TB meningitis) is an increasing global health concern.
  • This condition presents significant diagnostic and therapeutic challenges.
  • Both pulmonary and meningeal tuberculosis infections are affected by rising drug resistance.

Purpose of the Study:

  • To review diagnostic methods for tuberculous meningitis.
  • To examine current and experimental drug resistance assays.
  • To discuss patient management strategies for MDR-TB meningitis.

Main Methods:

  • Literature review of epidemiology, diagnostics, and treatment of MDR-TB meningitis.
  • Discussion of molecular methods for drug resistance determination.

Related Experiment Videos

  • Analysis of current and experimental therapeutic approaches.

    • Main Results:

    • The incidence of MDR-TB meningitis is rising worldwide.
    • Current diagnostic and treatment methods are insufficient for this growing challenge.
    • There is a critical need for improved organism isolation from cerebrospinal fluid and rapid molecular susceptibility testing.

    Conclusions:

    • Effective management of MDR-TB meningitis requires enhanced rapid diagnostic tools.
    • Development of novel antituberculosis drugs, particularly those penetrating the blood-cerebrospinal fluid barrier, is essential.
    • Advancing molecular techniques for antibiotic sensitivity testing is a key priority.